See more : National Investments Fund Limited (1227.HK) Income Statement Analysis – Financial Results
Complete financial analysis of Future Care Trading Co. (9544.SR) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Future Care Trading Co., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- Shivkamal Impex Limited (SHIVKAMAL.BO) Income Statement Analysis – Financial Results
- Okapi Resources Limited (OKR.AX) Income Statement Analysis – Financial Results
- Molten Ventures VCT plc (MVCT.L) Income Statement Analysis – Financial Results
- Hangzhou Weiguang Electronic Co.,Ltd. (002801.SZ) Income Statement Analysis – Financial Results
- Farglory Life Insurance Co., Ltd. (5859.TWO) Income Statement Analysis – Financial Results
Future Care Trading Co. (9544.SR)
About Future Care Trading Co.
Future Care Trading Co. provides a range of home healthcare and laboratory services in the Kingdom of Saudi Arabia. It offers nursing, physiotherapy, social, and nutritional and dietary therapy services, as well as nursing aids and doctor visits. The company was founded in 2015 and is based in Jeddah, the Kingdom of Saudi Arabia.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 50.98M | 34.12M | 72.03M | 58.57M | 30.34M | 16.92M |
| Cost of Revenue | 34.04M | 22.36M | 30.21M | 20.92M | 19.82M | 9.37M |
| Gross Profit | 16.94M | 11.76M | 41.82M | 37.66M | 10.52M | 7.55M |
| Gross Profit Ratio | 33.23% | 34.46% | 58.06% | 64.29% | 34.67% | 44.64% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 808.27K | 6.47M | 4.05M | 8.90M | 0.00 | 0.00 |
| Selling & Marketing | 830.32K | -477.03K | -499.01K | 1.97M | 0.00 | 0.00 |
| SG&A | 1.64M | 5.99M | 3.55M | 10.87M | 6.69M | 3.91M |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 1.33M | 5.99M | 3.55M | 10.87M | 6.69M | 3.91M |
| Cost & Expenses | 35.37M | 28.36M | 33.76M | 31.78M | 26.51M | 13.28M |
| Interest Income | 0.00 | 176.47K | 126.65K | 29.57K | 0.00 | 0.00 |
| Interest Expense | 179.84K | 176.47K | 126.65K | 29.57K | 23.28K | 0.00 |
| Depreciation & Amortization | -10.00 | 1.67M | 1.50M | 1.79M | 1.43M | 652.01K |
| EBITDA | 15.61M | 7.80M | 39.47M | 28.50M | 5.26M | 1.58M |
| EBITDA Ratio | 30.62% | 21.78% | 55.22% | 48.80% | 17.33% | 25.35% |
| Operating Income | 15.61M | 5.77M | 38.27M | 26.79M | 3.82M | 3.64M |
| Operating Income Ratio | 30.62% | 16.90% | 53.13% | 45.74% | 12.60% | 21.50% |
| Total Other Income/Expenses | -179.85K | 194.18K | -126.65K | -29.57K | -23.28K | -2.71M |
| Income Before Tax | 15.43M | 5.96M | 38.15M | 26.76M | 3.80M | 929.92K |
| Income Before Tax Ratio | 30.26% | 17.47% | 52.96% | 45.69% | 12.53% | 5.50% |
| Income Tax Expense | 1.77M | 834.13K | 1.44M | 803.13K | 220.02K | 42.51K |
| Net Income | 13.66M | 5.13M | 36.70M | 25.96M | 3.58M | 887.41K |
| Net Income Ratio | 26.80% | 15.02% | 50.95% | 44.31% | 11.80% | 5.25% |
| EPS | 0.03 | 0.01 | 0.40 | 2.60 | 0.36 | 0.09 |
| EPS Diluted | 0.03 | 0.01 | 0.40 | 2.60 | 0.36 | 0.09 |
| Weighted Avg Shares Out | 500.01M | 500.00M | 90.65M | 10.00M | 10.00M | 10.00M |
| Weighted Avg Shares Out (Dil) | 500.00M | 500.00M | 90.65M | 10.00M | 10.00M | 10.00M |
Source: https://incomestatements.info
Category: Stock Reports